Literature DB >> 22647521

Oxytocin enhances resting-state connectivity between amygdala and medial frontal cortex.

Chandra Sekhar Sripada1, K Luan Phan, Izelle Labuschagne, Robert Welsh, Pradeep J Nathan, Amanda G Wood.   

Abstract

The neuropeptide oxytocin (OXT) plays an important role in complex socio-affective behaviours such as affiliation, attachment, stress and anxiety. Previous studies have focused on the amygdala as an important target of OXT's effects. However, the effects of OXT on connectivity of the amygdala with cortical regions such as medial frontal cortex, an important mediator of social cognition and emotion regulation, remain unexplored. In a randomized, double-blind, cross-over design, 15 volunteers received intranasal OXT or placebo prior to resting-state functional magnetic resonance imaging. OXT significantly increased connectivity between both amygdalae and rostral medial frontal cortex (rmFC), while having only negligible effects on coupling with other brain regions. These results demonstrate that OXT is a robust and highly selective enhancer of amygdala connectivity with rmFC, a region critical to social cognition and emotion regulation, and add to our understanding of the neural mechanisms by which OXT modulates complex social and cognitive behaviours.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22647521     DOI: 10.1017/S1461145712000533

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  59 in total

Review 1.  Oxytocin and social cognition in affective and psychotic disorders.

Authors:  M Mercedes Perez-Rodriguez; Katie Mahon; Manuela Russo; Allison K Ungar; Katherine E Burdick
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-01       Impact factor: 4.600

2.  Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia.

Authors:  Leah H Rubin; Siyi Li; Li Yao; Sarah K Keedy; James L Reilly; Scot K Hill; Jeffrey R Bishop; C Sue Carter; Hossein Pournajafi-Nazarloo; Lauren L Drogos; Elliot Gershon; Godfrey D Pearlson; Carol A Tamminga; Brett A Clementz; Matcheri S Keshavan; Su Lui; John A Sweeney
Journal:  Schizophr Res       Date:  2018-07-06       Impact factor: 4.939

Review 3.  Concurrent Treatment of Substance Use and PTSD.

Authors:  Julianne C Flanagan; Kristina J Korte; Therese K Killeen; Sudie E Back
Journal:  Curr Psychiatry Rep       Date:  2016-08       Impact factor: 5.285

Review 4.  Biomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-Art, challenges, and opportunities for studying brain chemistry.

Authors:  Najmeh Khalili-Mahani; Serge A R B Rombouts; Matthias J P van Osch; Eugene P Duff; Felix Carbonell; Lisa D Nickerson; Lino Becerra; Albert Dahan; Alan C Evans; Jean-Paul Soucy; Richard Wise; Alex P Zijdenbos; Joop M van Gerven
Journal:  Hum Brain Mapp       Date:  2017-02-01       Impact factor: 5.038

Review 5.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

6.  A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder.

Authors:  Christopher S Stauffer; Vivek Musinipally; Angela Suen; Kara L Lynch; Brad Shapiro; Joshua D Woolley
Journal:  Addict Res Theory       Date:  2016-05-25

Review 7.  Oxytocin and Anxiety Disorders: Translational and Therapeutic Aspects.

Authors:  Wadih Jean Naja; Michaelangelo Pietro Aoun
Journal:  Curr Psychiatry Rep       Date:  2017-08-15       Impact factor: 5.285

8.  Oxytocin in the prelimbic medial prefrontal cortex reduces anxiety-like behavior in female and male rats.

Authors:  Sara Sabihi; Nicole E Durosko; Shirley M Dong; Benedetta Leuner
Journal:  Psychoneuroendocrinology       Date:  2014-03-29       Impact factor: 4.905

9.  Oxytocin modulation of amygdala functional connectivity to fearful faces in generalized social anxiety disorder.

Authors:  Stephanie M Gorka; Daniel A Fitzgerald; Izelle Labuschagne; Avinash Hosanagar; Amanda G Wood; Pradeep J Nathan; K Luan Phan
Journal:  Neuropsychopharmacology       Date:  2014-07-07       Impact factor: 7.853

Review 10.  A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research.

Authors:  Marilena M DeMayo; Yun Ju C Song; Ian B Hickie; Adam J Guastella
Journal:  Paediatr Drugs       Date:  2017-10       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.